High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variation.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
01 2020
Historique:
received: 27 03 2019
accepted: 29 10 2019
pubmed: 18 12 2019
medline: 16 4 2020
entrez: 18 12 2019
Statut: ppublish

Résumé

By developing a high-density murine immunophenotyping platform compatible with high-throughput genetic screening, we have established profound contributions of genetics and structure to immune variation (http://www.immunophenotype.org). Specifically, high-throughput phenotyping of 530 unique mouse gene knockouts identified 140 monogenic 'hits', of which most had no previous immunologic association. Furthermore, hits were collectively enriched in genes for which humans show poor tolerance to loss of function. The immunophenotyping platform also exposed dense correlation networks linking immune parameters with each other and with specific physiologic traits. Such linkages limit freedom of movement for individual immune parameters, thereby imposing genetically regulated 'immunologic structures', the integrity of which was associated with immunocompetence. Hence, we provide an expanded genetic resource and structural perspective for understanding and monitoring immune variation in health and disease.

Identifiants

pubmed: 31844327
doi: 10.1038/s41590-019-0549-0
pii: 10.1038/s41590-019-0549-0
pmc: PMC7338221
mid: EMS86707
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

86-100

Subventions

Organisme : Cancer Research UK
ID : FC001093
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R007748/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102972
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107059
Pays : United Kingdom
Organisme : Wellcome Trust
ID : FC001093
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : R01 GM118417
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG006370
Pays : United States
Organisme : Medical Research Council
ID : FC001093
Pays : United Kingdom
Organisme : Wellcome Trust (Wellcome)
ID : 100156/Z/12/Z
Pays : International
Organisme : Medical Research Council
ID : MC_UU_00008/6
Pays : United Kingdom

Références

Nakaya, H. I. et al. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12, 786–795 (2011).
pubmed: 21743478 pmcid: 3140559 doi: 10.1038/ni.2067
Sobolev, O. et al. Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events. Nat. Immunol. 17, 204–213 (2016).
pubmed: 26726811 pmcid: 6485475 doi: 10.1038/ni.3328
Tsang, J. S. et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 157, 499–513 (2014).
pubmed: 24725414 pmcid: 4139290 doi: 10.1016/j.cell.2014.03.031
Wei, S. C. et al. Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade. Cell 170, 1120–1133.e17 (2017).
pubmed: 28803728 pmcid: 5591072 doi: 10.1016/j.cell.2017.07.024
Brodin, P. et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 160, 37–47 (2015).
pubmed: 25594173 pmcid: 4302727 doi: 10.1016/j.cell.2014.12.020
Carr, E. J. et al. The cellular composition of the human immune system is shaped by age and cohabitation. Nat. Immunol. 17, 461–468 (2016).
pubmed: 26878114 pmcid: 4890679 doi: 10.1038/ni.3371
Patin, E. et al. Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors. Nat. Immunol. 19, 302–314 (2018).
pubmed: 29476184 doi: 10.1038/s41590-018-0049-7
Alpert, A. et al. A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring. Nat. Med. 25, 362–364 (2019).
pubmed: 30842675 pmcid: 6686855 doi: 10.1038/s41591-019-0381-y
Ellinghaus, D. et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat. Genet. 48, 510–518 (2016).
pubmed: 26974007 pmcid: 4848113 doi: 10.1038/ng.3528
Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979–986 (2015).
pubmed: 26192919 pmcid: 4881818 doi: 10.1038/ng.3359
Tsoi, L. C. et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44, 1341–1348 (2012).
pubmed: 23143594 pmcid: 3510312 doi: 10.1038/ng.2467
Orrù, V. et al. Genetic variants regulating immune cell levels in health and disease. Cell 155, 242–256 (2013).
pubmed: 24074872 pmcid: 5541764 doi: 10.1016/j.cell.2013.08.041
Nelms, K. A. & Goodnow, C. C. Genome-wide ENU mutagenesis to reveal immune regulators. Immunity 15, 409–418 (2001).
pubmed: 11567631 doi: 10.1016/S1074-7613(01)00199-6
Wang, T. et al. Real-time resolution of point mutations that cause phenovariance in mice. Proc. Natl Acad. Sci. USA 112, E440–E449 (2015).
pubmed: 25605905 pmcid: 4321302
Steri, M. et al. Overexpression of the cytokine BAFF and autoimmunity risk. N. Engl. J. Med 376, 1615–1626 (2017).
pubmed: 28445677 pmcid: 5605835 doi: 10.1056/NEJMoa1610528
Zhang, S.-Y. et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522–1527 (2007).
pubmed: 17872438 doi: 10.1126/science.1139522
Turnbull, C. et al. The 100 000 genomes project: bringing whole genome sequencing to the NHS. BMJ 361, k1687 (2018).
pubmed: 29691228 doi: 10.1136/bmj.k1687
Zambrowicz, B. P. & Sands, A. T. Knockouts model the 100 best-selling drugs—will they model the next 100? Nat. Rev. Drug Discov. 2, 38–51 (2003).
pubmed: 12509758 doi: 10.1038/nrd987
Skarnes, W. C. et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474, 337–342 (2011).
pubmed: 21677750 pmcid: 3572410 doi: 10.1038/nature10163
Saleheen, D. et al. Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity. Nature 544, 235–239 (2017).
pubmed: 28406212 pmcid: 5600291 doi: 10.1038/nature22034
White, J. K. et al. Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. Cell 154, 452–464 (2013).
pubmed: 23870131 pmcid: 3717207 doi: 10.1016/j.cell.2013.06.022
Rahim, A. et al. High throughput automated analysis of big flow cytometry data. Methods 134–135, 164–176 (2018).
pubmed: 29287915 doi: 10.1016/j.ymeth.2017.12.015
Cooper, G. S. & Stroehla, B. C. The epidemiology of autoimmune diseases. Autoimmun. Rev. 2, 119–125 (2003).
pubmed: 12848952 doi: 10.1016/S1568-9972(03)00006-5
Ananthakrishnan, A. N. Epidemiology and risk factors for IBD. 12, 205–217 (2015).
Zhou, X. et al. Circuit design features of a stable two-cell system. Cell 172, 744–747.e17 (2018).
pubmed: 29398113 doi: 10.1016/j.cell.2018.01.015 pmcid: 7377352
Byers, S. L., Wiles, M. V., Dunn, S. L. & Taft, R. A. Mouse estrous cycle identification tool and images. PLoS One 7, e35538 (2012).
pubmed: 22514749 pmcid: 3325956 doi: 10.1371/journal.pone.0035538
Huang, S. C.-C. et al. Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation. Immunity 45, 817–830 (2016).
pubmed: 27760338 pmcid: 5535820 doi: 10.1016/j.immuni.2016.09.016
Kolev, M. et al. Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses. Immunity 42, 1033–1047 (2015).
pubmed: 26084023 pmcid: 4518498 doi: 10.1016/j.immuni.2015.05.024
Salvagno, G. L., Sanchis-Gomar, F., Picanza, A. & Lippi, G. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit. Rev. Clin. Lab. Sci. 52, 86–105 (2015).
pubmed: 25535770 doi: 10.3109/10408363.2014.992064
Olumuyiwa-Akeredolu, O. O. & Pretorius, E. Platelet and red blood cell interactions and their role in rheumatoid arthritis. Rheumatol. Int. 35, 1955–1964 (2015).
pubmed: 26059943 doi: 10.1007/s00296-015-3300-7
Pilling, L. C., Atkins, J. L., Kuchel, G. A., Ferrucci, L. & Melzer, D. Red cell distribution width and common disease onsets in 240,477 healthy volunteers followed for up to 9 years. PLoS One 13, e0203504 (2018).
pubmed: 30212481 pmcid: 6136726 doi: 10.1371/journal.pone.0203504
Xuan, C. et al. RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene. Oncogene 32, 3711–3721 (2012).
pubmed: 22926524 doi: 10.1038/onc.2012.386
Barbee, S. D. et al. Skint-1 is a highly specific, unique selecting component for epidermal T cells. Proc. Natl Acad. Sci. USA 108, 3330–3335 (2011).
pubmed: 21300860 doi: 10.1073/pnas.1010890108 pmcid: 3044407
Narita, T., Nitta, T., Nitta, S., Okamura, T. & Takayanagi, H. Mice lacking all of the Skint family genes. Int. Immunol. 30, 301–309 (2018).
pubmed: 29718261 doi: 10.1093/intimm/dxy030
Liu, S. et al. Diphthamide modification on eukaryotic elongation factor 2 is needed to assure fidelity of mRNA translation and mouse development. Proc. Natl Acad. Sci. USA 109, 13817–13822 (2012).
pubmed: 22869748 doi: 10.1073/pnas.1206933109 pmcid: 3427129
Chen, C.-M. & Behringer, R. R. Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis. Genes Dev. 18, 320–332 (2004).
pubmed: 14744934 pmcid: 338284 doi: 10.1101/gad.1162204
Liu, S. et al. Dph3, a small protein required for diphthamide biosynthesis, is essential in mouse development. Mol. Cell. Biol. 26, 3835–3841 (2006).
pubmed: 16648478 pmcid: 1488998 doi: 10.1128/MCB.26.10.3835-3841.2006
Jackson, R. et al. The translation of non-canonical open reading frames controls mucosal immunity. Nature 564, 434–438 (2018).
pubmed: 30542152 doi: 10.1038/s41586-018-0794-7 pmcid: 6939389
Grasberger, H. & Refetoff, S. Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. J. Biol. Chem. 281, 18269–18272 (2006).
pubmed: 16651268 doi: 10.1074/jbc.C600095200
Christodoulou, K. et al. Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes. Gut 62, 977–984 (2013).
pubmed: 22543157 doi: 10.1136/gutjnl-2011-301833
Cooper, J. D. et al. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat. Genet. 40, 1399–1401 (2008).
pubmed: 18978792 pmcid: 2635556 doi: 10.1038/ng.249
Liu, W. et al. Identification of BACH2 as a susceptibility gene for Graves’ disease in the Chinese Han population based on a three-stage genome-wide association study. Hum. Genet. 133, 661–671 (2014).
pubmed: 24346624 doi: 10.1007/s00439-013-1404-2
Roychoudhuri, R. et al. BACH2 represses effector programs to stabilize T
pubmed: 23728300 pmcid: 3710737 doi: 10.1038/nature12199
Afzali, B. et al. BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency. Nat. Immunol. 18, 813–823 (2017).
pubmed: 28530713 pmcid: 5593426 doi: 10.1038/ni.3753
Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016).
pubmed: 27535533 pmcid: 5018207
Karczewski, K. J. et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. Preprint at bioRxiv https://dx.doi.org/10.1101/531210 (2019).
Goltsev, Y. et al. Deep profiling of mouse splenic architecture with CODEX multiplexed imaging. Cell 174, 968–981.e15 (2018).
pubmed: 30078711 pmcid: 6086938 doi: 10.1016/j.cell.2018.07.010
Piasecka, B. et al. Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges. Proc. Natl Acad. Sci. USA 115, E488–E497 (2018).
pubmed: 29282317 doi: 10.1073/pnas.1714765115
Zalocusky, K. A. et al. The 10,000 immunomes project: building a resource for human immunology. Cell Rep. 25, 513–522.e3 (2018).
pubmed: 30304689 pmcid: 6263160 doi: 10.1016/j.celrep.2018.09.021
Márquez, A. et al. A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus. Ann. Rheum. Dis. 76, 286–294 (2017).
pubmed: 27193031 doi: 10.1136/annrheumdis-2016-209436
Liu, Y. et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4, e1000041 (2008).
pubmed: 18369459 pmcid: 2274885 doi: 10.1371/journal.pgen.1000041
Kuijpers, T. W. et al. Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B deficiency. J. Allergy Clin. Immunol. 140, 273–277.e10 (2017).
pubmed: 27965109 doi: 10.1016/j.jaci.2016.09.061
Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998–1013.e20 (2018).
pubmed: 30388456 pmcid: 6641984 doi: 10.1016/j.cell.2018.10.038
Karp, N. A. et al. Applying the ARRIVE guidelines to an in vivo database. PLoS Biol. 13, e1002151 (2015).
pubmed: 25992600 pmcid: 4439173 doi: 10.1371/journal.pbio.1002151
Karp, N. A. Robust and sensitive analysis of mouse knockout phenotypes. PLoS One 7, e52410 (2012).
pubmed: 23300663 pmcid: 3530558 doi: 10.1371/journal.pone.0052410
Karp, N. A. et al. Impact of temporal variation on design and analysis of mouse knockout phenotyping studies. PLoS One 9, e111239 (2014).
pubmed: 25343444 pmcid: 4208881 doi: 10.1371/journal.pone.0111239
Ryder, E. et al. Molecular characterization of mutant mouse strains generated from the EUCOMM/KOMP-CSD ES cell resource. Mamm. Genome 24, 286–294 (2013).
pubmed: 23912999 pmcid: 3745610 doi: 10.1007/s00335-013-9467-x
Malek, M. et al. flowDensity: reproducing manual gating of flow cytometry data by automated density-based cell population identification. Bioinformatics 31, 606–607 (2015).
pubmed: 25378466 doi: 10.1093/bioinformatics/btu677
Mason, J. et al. Prevalence of sexual dimorphism in mammalian phenotypic traits. Nat. Commun. 8, 15475 (2017).
pubmed: 28650954 pmcid: 5490203 doi: 10.1038/ncomms15475
Mi, H., Muruganujan, A., Ebert, D., Huang, X. & Thomas, P. D. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 47, D419–D426 (2018).
pmcid: 6323939 doi: 10.1093/nar/gky1038
Kurbatova, N., Mason, J. C., Morgan, H., Meehan, T. F. & Karp, N. A. PhenStat: a tool kit for standardized analysis of high throughput phenotypic data. PLoS One 10, e0131274 (2015).
pubmed: 26147094 pmcid: 4493137 doi: 10.1371/journal.pone.0131274

Auteurs

Lucie Abeler-Dörner (L)

Department of Immunobiology, King's College London, London, UK.

Adam G Laing (AG)

Department of Immunobiology, King's College London, London, UK.
The Francis Crick Institute, London, UK.

Anna Lorenc (A)

Department of Immunobiology, King's College London, London, UK.
The Francis Crick Institute, London, UK.

Dmitry S Ushakov (DS)

Department of Immunobiology, King's College London, London, UK.
The Francis Crick Institute, London, UK.

Simon Clare (S)

Wellcome Sanger Institute, Hinxton, UK.

Anneliese O Speak (AO)

Wellcome Sanger Institute, Hinxton, UK.

Maria A Duque-Correa (MA)

Wellcome Sanger Institute, Hinxton, UK.

Jacqueline K White (JK)

Wellcome Sanger Institute, Hinxton, UK.

Ramiro Ramirez-Solis (R)

Wellcome Sanger Institute, Hinxton, UK.

Namita Saran (N)

Department of Immunobiology, King's College London, London, UK.

Katherine R Bull (KR)

MRC Human Immunology Unit, University of Oxford, Oxford, UK.

Belén Morón (B)

Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.

Jua Iwasaki (J)

National Heart and Lung Institute, Imperial College London, London, UK.

Philippa R Barton (PR)

Cambridge Institute of Medical Research, University of Cambridge, Cambridge, UK.

Susana Caetano (S)

Department of Immunobiology, King's College London, London, UK.
Wellcome Sanger Institute, Hinxton, UK.

Keng I Hng (KI)

Department of Immunobiology, King's College London, London, UK.

Emma Cambridge (E)

Wellcome Sanger Institute, Hinxton, UK.

Simon Forman (S)

Lydia Becker Institute of Immunology and Inflammation, Wellcome Trust Centre for Cell Matrix Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Tanya L Crockford (TL)

MRC Human Immunology Unit, University of Oxford, Oxford, UK.

Mark Griffiths (M)

Wellcome Sanger Institute, Hinxton, UK.

Leanne Kane (L)

Wellcome Sanger Institute, Hinxton, UK.

Katherine Harcourt (K)

Wellcome Sanger Institute, Hinxton, UK.

Cordelia Brandt (C)

Wellcome Sanger Institute, Hinxton, UK.

George Notley (G)

Wellcome Sanger Institute, Hinxton, UK.

Kolawole O Babalola (KO)

European Bioinformatics Institute, European Molecular Biology Laboratory, Hinxton, UK.

Jonathan Warren (J)

European Bioinformatics Institute, European Molecular Biology Laboratory, Hinxton, UK.

Jeremy C Mason (JC)

European Bioinformatics Institute, European Molecular Biology Laboratory, Hinxton, UK.

Amrutha Meeniga (A)

European Bioinformatics Institute, European Molecular Biology Laboratory, Hinxton, UK.

Natasha A Karp (NA)

Data Sciences & Quantitative Biology, Discovery Sciences, R&D Biopharmaceuticals, AstraZeneca, Cambridge, UK.

David Melvin (D)

Wellcome Sanger Institute, Hinxton, UK.

Eleanor Cawthorne (E)

MRC Human Immunology Unit, University of Oxford, Oxford, UK.

Brian Weinrick (B)

Department of Microbiology and Immunology, Department of Molecular Genetics, Albert Einstein College of Medicine, Bronx, NY, USA.

Albina Rahim (A)

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.

Sibyl Drissler (S)

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.

Justin Meskas (J)

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.

Alice Yue (A)

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.

Markus Lux (M)

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.

George X Song-Zhao (GX)

Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.

Anna Chan (A)

Department of Immunobiology, King's College London, London, UK.

Carmen Ballesteros Reviriego (C)

Wellcome Sanger Institute, Hinxton, UK.

Johannes Abeler (J)

Department of Economics, University of Oxford, Oxford, UK.

Heather Wilson (H)

Wellcome Sanger Institute, Hinxton, UK.

Agnieszka Przemska-Kosicka (A)

Department of Immunobiology, King's College London, London, UK.

Matthew Edmans (M)

MRC Human Immunology Unit, University of Oxford, Oxford, UK.

Natasha Strevens (N)

Wellcome Sanger Institute, Hinxton, UK.

Markus Pasztorek (M)

Department of Immunobiology, King's College London, London, UK.
Department of Biomedical Science, University of Applied Sciences FH Campus Wien, Vienna, Austria.

Terrence F Meehan (TF)

European Bioinformatics Institute, European Molecular Biology Laboratory, Hinxton, UK.

Fiona Powrie (F)

The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.

Ryan Brinkman (R)

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
Department of Bioinformatics, University of British Columbia, Vancouver, BC, Canada.

Gordon Dougan (G)

Wellcome Sanger Institute, Hinxton, UK.

William Jacobs (W)

Department of Microbiology and Immunology, Department of Molecular Genetics, Albert Einstein College of Medicine, Bronx, NY, USA.

Clare M Lloyd (CM)

National Heart and Lung Institute, Imperial College London, London, UK.

Richard J Cornall (RJ)

MRC Human Immunology Unit, University of Oxford, Oxford, UK.

Kevin J Maloy (KJ)

Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK.

Richard K Grencis (RK)

Lydia Becker Institute of Immunology and Inflammation, Wellcome Trust Centre for Cell Matrix Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Gillian M Griffiths (GM)

Cambridge Institute of Medical Research, University of Cambridge, Cambridge, UK.

David J Adams (DJ)

Wellcome Sanger Institute, Hinxton, UK.

Adrian C Hayday (AC)

Department of Immunobiology, King's College London, London, UK. adrian.hayday@kcl.ac.uk.
The Francis Crick Institute, London, UK. adrian.hayday@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH